USA flag logo/image

An Official Website of the United States Government

ANALYSIS OF DIGOXIN IN SERUM USING A SIMPLE IMMUNOASSAY

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
3239
Program Year/Program:
1986 / SBIR
Agency Tracking Number:
3239
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
GENESIS LABORATORIES, INC
10122 NE FRONTAGE RD Wellington, CO 80549 1703
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 1986
Title: ANALYSIS OF DIGOXIN IN SERUM USING A SIMPLE IMMUNOASSAY
Agency: HHS
Contract: N/A
Award Amount: $445,000.00
 

Abstract:

THE LONG-TERM OBJECTIVE OF THIS WORK IS TO DEVELOP A RAPID, COLORIMETRIC, INSTRUMENT-DEPENDENT ASSAY FOR CARDIO-DIGITALIS CONSTITUENTS, NOTABLY DIGOXIN AND DIGITOXIN. GENESIS LABS' ""IMMUNOSTRIP'' ASSAY (PROTECTED BY PATENT) IS CONSTRUCTED IN A CONFIGURATION THAT IS APPLICABLE FOR THE RAPID DETECTION OF DRUGS AND METABOLITES IN BIOLOGICAL FLUIDS, E.G., URINE, BLOOD, OR SALIVA. THE RELATIVE SIMPLICITY OF THE METHOD SUGGESTS ITS EASY USE BY MEDICALLY UNSOPHISTICATED INDIVIDUALS. WE WILL ATTEMPT INITIALLY TO DETERMINE DIGOXIN IN SERUM AT A LEVEL OF 5 NG/ML. ULTIMATELY, OUR AIM IS TO INCREASE THE SENSITIVITY OF THE ASSAY SYSTEM INTO THE 15 NG/ML RANGE. THIS WILL REQUIRE THE USE OF A HAND-HELD REFLECTOMETER ($1000 PER UNIT CURRENTLY) FOR READING THE STRIPS. HOWEVER, IT IS FEASIBLE BY VARYING THE AMOUNT OF ANTIGEN AND ENZYME MODIFIED ANTIDIGOXIN ANTIBODY WITHIN THE IMMUNOSTRIP THAT WE CAN PRODUCE A VISUAL ASSAY WITHIN THIS LOWER RANGE. THE ASSAY HAS MANY APPLICATIONS FOR MONITORING THERAPEUTIC DRUGS, INCLUDING DIGOXIN, AND THEREFORE WILL HAVE A MAJOR IMPACT ON OUR KNOWLEDGE OF THE HEALTH BENEFIT/RISK RATIO WITHIN POPULATIONS OF OUR SOCIETY WHO REQUIRE DRUGS. BASED ON OUR ABILITY TO MONITOR OTHER HORMONES, DRUGS, AND SMALL HAPTENS USING THIS ASSAY, WE FEEL CONFIDENT THAT IN THE FUTURE, BY USING HIGHLY SPECIFIC POLYCLONAL ANTISERA OR MORE LIKELY MONOCLONAL ANTIBODIES, IT MAY BE POSSIBLE TO MONITOR ACTIVE DIGOXIN AND THEREBY PREDICT THERAPEUTIC VERSUS TOXIC LEVELS OF DIGOXIN IN A PHYSICIAN'S OFFICE WITH A ONE-MINUTE TEST.

Principal Investigator:

Alan R. Day
Principal Investigator
6128353446

Business Contact:

Small Business Information at Submission:

Genesis Laboratorys, Inc.
5245 Edina Industrial Blvd. Edina, MN 55435

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No